SB-431542 inhibits TGF-beta-induced contraction of collagen gel by normal and keloid fibroblasts. 2005

Toshio Hasegawa, and Atsuhito Nakao, and Koji Sumiyoshi, and Hitoshi Tsuchihashi, and Hideoki Ogawa
Department of Dermatology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.

BACKGROUND Transforming growth factor (TGF)-beta induces fibroblast contraction, which is implicated in wound healing and keloid formation. SB-431542 is a novel specific inhibitor of TGF-beta type I receptor kinase activity. OBJECTIVE We sought to determine whether SB-431542 inhibited TGF-beta-induced fibroblast contraction. METHODS We used an in vitro type I collagen gel contraction assay with normal or keloid dermal fibroblasts incorporated. RESULTS TGF-beta induced contraction of collagen gels with normal dermal fibroblasts incorporated, which was efficiently suppressed by SB-431542. Keloid fibroblasts showed higher basal contraction of collagen gels in the absence of TGF-beta than normal fibroblasts, which was enhanced by addition of TGF-beta. SB-431542 suppressed both the basal and TGF-beta-enhanced contraction of collagen gels by keloid fibroblasts. These inhibitory effects of SB-431542 were associated with suppression of TGF-beta-induced alpha-smooth muscle actin (alpha-SMA) expression and phosphorylation of Smad2 in normal and keloid fibroblasts. CONCLUSIONS SB-431542 can suppress TGF-beta-induced contraction of collagen gel by normal and keloid dermal fibroblasts. Importantly, SB-431542 can inhibit basal contraction of collagen gel by keloid fibroblasts. These results suggest that an inhibitor of TGF-beta type I receptor kinase activity may have therapeutic potential for excessive skin contraction as observed in keloid.

UI MeSH Term Description Entries
D007627 Keloid A sharply elevated, irregularly shaped, progressively enlarging scar resulting from formation of excessive amounts of collagen in the dermis during connective tissue repair. It is differentiated from a hypertrophic scar (CICATRIX, HYPERTROPHIC) in that the former does not spread to surrounding tissues. Keloids
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004149 Dioxoles
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005782 Gels Colloids with a solid continuous phase and liquid as the dispersed phase; gels may be unstable when, due to temperature or other cause, the solid phase liquefies; the resulting colloid is called a sol.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000199 Actins Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle. F-Actin,G-Actin,Actin,Isoactin,N-Actin,alpha-Actin,alpha-Isoactin,beta-Actin,gamma-Actin,F Actin,G Actin,N Actin,alpha Actin,alpha Isoactin,beta Actin,gamma Actin
D001549 Benzamides BENZOIC ACID amides.
D016212 Transforming Growth Factor beta A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins. Bone-Derived Transforming Growth Factor,Platelet Transforming Growth Factor,TGF-beta,Milk Growth Factor,TGFbeta,Bone Derived Transforming Growth Factor,Factor, Milk Growth,Growth Factor, Milk

Related Publications

Toshio Hasegawa, and Atsuhito Nakao, and Koji Sumiyoshi, and Hitoshi Tsuchihashi, and Hideoki Ogawa
February 2009, Wounds : a compendium of clinical research and practice,
Toshio Hasegawa, and Atsuhito Nakao, and Koji Sumiyoshi, and Hitoshi Tsuchihashi, and Hideoki Ogawa
January 2018, International journal of ophthalmology,
Toshio Hasegawa, and Atsuhito Nakao, and Koji Sumiyoshi, and Hitoshi Tsuchihashi, and Hideoki Ogawa
February 2021, Cytokine,
Toshio Hasegawa, and Atsuhito Nakao, and Koji Sumiyoshi, and Hitoshi Tsuchihashi, and Hideoki Ogawa
January 2006, Biochemical and biophysical research communications,
Toshio Hasegawa, and Atsuhito Nakao, and Koji Sumiyoshi, and Hitoshi Tsuchihashi, and Hideoki Ogawa
January 2023, International journal of ophthalmology,
Toshio Hasegawa, and Atsuhito Nakao, and Koji Sumiyoshi, and Hitoshi Tsuchihashi, and Hideoki Ogawa
February 2016, Die Pharmazie,
Toshio Hasegawa, and Atsuhito Nakao, and Koji Sumiyoshi, and Hitoshi Tsuchihashi, and Hideoki Ogawa
June 2009, Burns : journal of the International Society for Burn Injuries,
Toshio Hasegawa, and Atsuhito Nakao, and Koji Sumiyoshi, and Hitoshi Tsuchihashi, and Hideoki Ogawa
June 1990, Investigative ophthalmology & visual science,
Toshio Hasegawa, and Atsuhito Nakao, and Koji Sumiyoshi, and Hitoshi Tsuchihashi, and Hideoki Ogawa
May 1994, Investigative ophthalmology & visual science,
Toshio Hasegawa, and Atsuhito Nakao, and Koji Sumiyoshi, and Hitoshi Tsuchihashi, and Hideoki Ogawa
June 2005, The Journal of biological chemistry,
Copied contents to your clipboard!